| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director | Common stock | 15,483 | $756 K | $48.84 | Jun 13, 2024 | Direct |
| AGIOS PHARMACEUTICALS, INC. | Director | Restricted stock units | 2,120 | $104 K | $48.84 | Jun 20, 2024 | Direct |
| Carisma Therapeutics Inc. | Director | Stock Option (Right to Buy) | 38,700 | Jul 1, 2024 | Direct | ||
| Editas Medicine, Inc. | Director | Stock Option (right to buy) | 25,000 | May 30, 2024 | Direct | ||
| Magenta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20,000 | Jun 28, 2022 | Direct | ||
| AGIOS PHARMACEUTICALS, INC. | Director | Stock options (right to buy) | 11,774 | Jun 20, 2024 | Direct |